Virus filtration is a key downstream processing step in biopharmaceutical manufacturing to remove viral contaminants from cell culture media, bulk harvest material, or final drug product. It utilizes size-exclusion membrane filters or filters with other mechanisms, such as adsorption, to physically separate viruses from therapeutics including monoclonal antibodies, vaccines, gene therapy vectors and others. The global virus filtration market is gaining traction owing to the increasing demand for biologics, which require virus removal during manufacturing.

The global Virus Filtration Market is estimated to be valued at US$ 5.86 Million in 2024 and is expected to exhibit a CAGR Of 3.1% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Increased demand for biologics: With the growing demand for biologics worldwide as treatment options for various chronic diseases such as cancer, viral contamination during manufacturing needs to be prevented to avoid any safety issues. As biologics account for a large share of the pipeline drugs under development and clinical trials, the demand for virus filtration is growing substantially.

Stringent regulatory :

Regulatory agencies like US FDA and EMA have stringent guidelines to check viral contamination during manufacturing of biologics and vaccines. Virus filtration is a mandatory step to prevent any virus carry-over during drug production. Hence, adherence to regulatory norms is driving the adoption of virus filtration solutions in the biopharmaceutical industry.

Segment Analysis

The virus filtration market can be segmented by product ( consumables, instruments, and services), application (biological vaccines, blood and blood products), and end user (contract manufacturing organizations, academic research institutes, and the biopharmaceutical industry).The consumable segment is dominating the market currently due to the continuous process of filtration which requires virus removal or clearance at each step of downstream purification in biological manufacturing. Over the years there has been increasing demand of biological drugs and vaccines which has driven the growth of consumables segment in virus filtration market.

PEST Analysis

Political: Government regulations regarding stringent quality standards in biological manufacturing have increased the demand for virus filtration.

Economic: Growth of biopharmaceutical industry and rise in monoclonal antibody therapeutics market are driving the virus filtration market growth.

Social: Increase in incidence of chronic diseases and viral infectious diseases have boosted research activities in biological drugs development which requires virus filtration.

Technological: Advancements in virus filtration membranes, chromatography resins and equipment have improved throughput and ability to clear wide range of viruses from biological products.

Key Takeaways

The Global Virus Filtration Market Demand  is expected to witness high growth over the forecast period of 2024 to 2031. The global virus filtration Market is estimated to be valued at US$ 5.86 million in 2024 and is expected to exhibit a CAGR of 3.1% over the forecast period 2024-2031.

Regional analysis shows North America dominates currently due to presence of major players and stringent regulations for biologics production. Europe and Asia Pacific regions are expected to be fastest growing regions due to growing biopharma industry.

Key players operating in the virus filtration market are Astellas Pharma, Genzyme Corporation, Accord Healthcare Lt. Key players are focusing on new product launches, partnerships and expansion to increase their market share. Astellas Pharma and Genzyme Corporation being the major players dominating the filtration systems and consumables segment.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it